Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide

被引:31
作者
Saifullah, Bullo [1 ]
Arulselvan, Palanisamy [2 ]
El, Mohamed Ezzat Zowalaty [3 ]
Fakurazi, Harida [2 ,4 ]
Webster, Thomas J. [2 ,5 ,6 ,7 ]
Geilich, Benjamin M. [5 ,6 ]
Hussein, Mohd Zobir [1 ]
机构
[1] Univ Putra Malaysia, Inst Adv Technol, Mat Synth & Characterizat Lab, Serdang 43400, Selangor, Malaysia
[2] Univ Putra Malaysia, Inst Biosci, Lab Vaccines & Immunotherapeut, Serdang 43400, Selangor, Malaysia
[3] Jazan Univ, Fac Publ Hlth & Trop Med, Dept Environm Hlth, Jazan, Saudi Arabia
[4] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang 43400, Selangor, Malaysia
[5] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA
[6] Northeastern Univ, Bioengn Program, Boston, MA 02115 USA
[7] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia
关键词
tuberculosis; isoniazid; Mg/Al LDH; nanodelivery system; GROWTH INDICATOR TUBE; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; IN-VITRO; HEPATOTOXICITY; RIFAMPIN; SUSCEPTIBILITY; NANOPARTICLES; PYRAZINAMIDE;
D O I
10.2147/IJN.S63608
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The primary challenge in finding a treatment for tuberculosis (TB) is patient non-compliance to treatment due to long treatment duration, high dosing frequency, and adverse effects of anti-TB drugs. This study reports on the development of a nanodelivery system that intercalates the anti-TB drug isoniazid into Mg/Al layered double hydroxides (LDHs). Isoniazid was found to be released in a sustained manner from the novel nanodelivery system in humans in simulated phosphate buffer solutions at pH 4.8 and pH 7.4. The nanodelivery formulation was highly biocompatible compared to free isoniazid against human normal lung and 3T3 mouse fibroblast cells. The formulation was active against Mycobacterium tuberculosis and gram-positive bacteria and gram-negative bacteria. Thus results show significant promise for the further study of these nanocomposites for the treatment of TB.
引用
收藏
页码:4749 / 4762
页数:14
相关论文
共 43 条
[21]   Inorganic Metal Hydroxide Nanoparticles for Targeted Cellular Uptake Through Clathrin-Mediated Endocytosis [J].
Oh, Jae-Min ;
Choi, Soo-Jin ;
Lee, Go-Eun ;
Kim, Jung-Eun ;
Choy, Jin-Ho .
CHEMISTRY-AN ASIAN JOURNAL, 2009, 4 (01) :67-73
[22]   Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens [J].
Palaci, M ;
Ueki, SYM ;
Sato, DN ;
Telles, MAD ;
Curcio, M ;
Silva, EAM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :762-764
[23]   Carbonate intercalated Zn/Fe layered double hydroxide: A novel photocatalyst for the enhanced photo degradation of azo dyes [J].
Parida, K. M. ;
Mohapatra, Lagnamayee .
CHEMICAL ENGINEERING JOURNAL, 2012, 179 :131-139
[24]   Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management [J].
Ramappa, Vidyasagar ;
Aithal, Guruprasad P. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (01) :37-49
[25]  
Rives V, 2001, LAYERED DOUBLE HYDRO, V22, P75
[26]   Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites [J].
Saifullah, Bullo ;
Hussein, Mohd Zobir ;
Hussein-Al-Ali, Samer Hasan ;
Arulselvan, Palanisamy ;
Fakurazi, Sharida .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :1365-1375
[27]   Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite [J].
Saifullah, Bullo ;
Hussein, Mohd Zobir ;
Hussein-Al-Ali, Samer Hasan ;
Arulselvan, Palanisamy ;
Fakurazi, Sharida .
CHEMISTRY CENTRAL JOURNAL, 2013, 7
[28]   Controlled-release approaches towards the chemotherapy of tuberculosis [J].
Saifullah, Bullo ;
Hussein, Mohd Zobir B. ;
Al Ali, Samer Hasan Hussein .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 :5451-5463
[29]   Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis [J].
Schaberg, T ;
Rebhan, K ;
Lode, H .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (10) :2026-2030
[30]  
Sharma SK, 2004, INDIAN J MED RES, V120, P316